CASDIN CAPITAL, LLC – Agios Pharmaceuticals, Inc. Transaction History
CASDIN CAPITAL, LLC portfolio value:
$0
portfolio value
CASDIN CAPITAL, LLC quarter portfolio value change:
+27.56%
quarter
Agios Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -100.00% | -785K shares | -17.40M | $28.28 | 0 |
Q2 2022 | share | Decrease | -62.44% | -1.30M shares | -43.43M | $22.17 | 785K |
Q1 2022 | share | 0.00% | 0 shares | -7.85M | $29.11 | 2.09M | |
Q4 2021 | share | Decrease | -3.46% | -75K shares | -31.21M | $33.57 | 2.09M |
Q3 2021 | share | 0.00% | 0 shares | -19.39M | $46.15 | 2.16M | |
Q2 2021 | share | 0.00% | 0 shares | 7.51M | $55.11 | 2.16M | |
Q1 2021 | share | Decrease | -8.84% | -210K shares | 8.89M | $51.64 | 2.16M |
Q4 2020 | share | Increase | +35.71% | 625K shares | 41.65M | $43.33 | 2.37M |
Q3 2020 | share | Increase | +63.55% | 680K shares | 4.02M | $35 | 1.75M |
Q2 2020 | share | 0.00% | 0 shares | 19.26M | $53.48 | 1.07M | |
Q1 2020 | share | Increase | +29.70% | 245K shares | -1.43M | $35.48 | 1.07M |
Q4 2019 | share | Decrease | -11.76% | -110K shares | 9.1M | $47.75 | 825K |
Q3 2019 | share | Increase | +88.89% | 440K shares | 5.60M | $32.4 | 935K |
Q2 2019 | share | Increase | +47.76% | 160K shares | 2.09M | $49.88 | 495K |
Q1 2019 | share | Decrease | -24.72% | -110K shares | 2.07M | $67.44 | 335K |
Q4 2018 | share | Decrease | -23.25% | -134.77K shares | -24.19M | $46.11 | 445K |
Q3 2018 | share | Increase | +58.94% | 215K shares | 13.98M | $77.12 | 579.77K |
Q2 2018 | share | 0.00% | 0 shares | 894K | $84.23 | 364.77K | |
Q1 2018 | call | Decrease | -100.00% | -25K shares | -1.42M | $81.78 | 0 |
Q1 2018 | share | Increase | +23.65% | 69.77K shares | 12.96M | $81.78 | 364.77K |
Q4 2017 | call | Increase | 0.00% | 25K shares | 1.42M | $57.17 | 25K |
Q4 2017 | share | Increase | +15.69% | 40K shares | -156K | $57.17 | 295K |
Q3 2017 | share | 0.00% | 0 shares | 3.90M | $66.75 | 255K | |
Q2 2017 | share | Increase | +7.37% | 17.5K shares | -750K | $51.45 | 255K |
Q1 2017 | share | Decrease | -1.25% | -3K shares | 3.83M | $58.4 | 237.5K |
Q4 2016 | share | Decrease | -14.85% | -41.94K shares | -4.88M | $41.73 | 240.5K |
Q3 2016 | share | Increase | +50.64% | 94.94K shares | 7.06M | $52.82 | 282.44K |
Q2 2016 | share | Increase | +26.69% | 39.5K shares | 1.84M | $41.9 | 187.5K |
Q1 2016 | call | Decrease | -100.00% | -5K shares | -325K | $40.6 | 0 |
Q1 2016 | share | Increase | +53.37% | 51.5K shares | -256K | $40.6 | 148K |